Author

Z. Li

Observed name: Zhenguo Li

Observed institutions: Beijing Tongren Hospital, Capital Medical University

OpenAlex ID: A5079358572

EP08.02-033 Anlotinib in Elderly Patients With Advanced Non-squamous NSCLC Who Had Not Received Systemic Chemotherapy: A Single-Arm, Phase II Study

2022 · d. zhao, x. hou, et al. · Journal of Thoracic Oncology · 1

A Th17-centered immune network for tertiary lymphoid structure formation in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy

2026 · Zihang Mai, Qianlong Wu, et al. · Drug Resistance Updates

1347P Exploration of post-treatment strategies following neoadjuvant PD-1 inhibitor combined with chemotherapy in resectable locally advanced oropharyngeal/hypopharyngeal/laryngeal squamous cell carcinoma (OP/HP/LSCC)

2025 · X. Chen, Z. Li, et al. · Annals of Oncology

Works count: 3

Citation count: 1

H-index: 1

I10-index: